Approved Uses and Important Safety Information

What is ACTIMMUNE® (Interferon gamma-1b) used for?

ACTIMMUNE is used to treat chronic granulomatous disease, or CGD. CGD is a genetic disorder, usually diagnosed in childhood, that affects some cells of the immune system and the body’s risk of serious infection

ACTIMMUNE is also used to slow the worsening of severe, malignant osteopetrosis (SMO). SMO is a genetic disorder that affects normal bone formation and is usually diagnosed in the first few months after birth.

Read more Close

Helpful resources for SMO

You can find more information and support groups for people affected by severe malignant osteopetrosis (SMO) through the organizations listed below.
 

Ryan Wersten MIOP Foundation

The Ryan Wersten MIOP Foundation was created in memory of Ryan Wersten. Ryan lived for only 6 months after being diagnosed with malignant infantile osteopetrosis (MIOP), also known as severe infantile osteopetrosis. The Ryan Wersten MIOP Foundation is dedicated to supporting current research and to supporting families who have a child with MIOP.

 

Mason Shaffer Foundation

The Mason Shaffer Foundation is a nonprofit organization dedicated to creating a support network for families of children with osteopetrosis.
 

The OsteoPETrosis Society (OPETS)

The OPETS is an organization that provides education and support to people diagnosed with osteopetrosis and medical professionals dealing with the disease. The society conducts an annual patient meeting with informative sessions for patients and has established a medical advisory council that provides expertise in the field of osteopetrosis.
 

Global Genes | RARE Project

Global Genes | RARE Project is a leading patient advocacy organization working to connect and empower rare disease patients and caregivers to become successful advocates by providing tools and resources and creating shared learnings to educate and inform. The mission of Global Genes | RARE Project is to build and unify a global rare and genetic disease community while positively impacting patients in their lifetime.